| MACULOPATHIE ET AUTRES ANOMALIES | |||||||||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| OD | 12 | 41 | 1 | 3 | 0 | 2 | 59 | ||
| OG | 15 | 37 | 1 | 3 | 0 | 3 | 59 | ||
| OD + OG | 27 | 78 | 2 | 6 | 0 | 5 | 118 | ||
| N/A | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | ||||
| OD | 20,34% | 69,49% | 1,69% | 5,08% | 0,00% | 3,39% | 100,00% | ||
| OG | 25,42% | 62,71% | 1,69% | 5,08% | 0,00% | 5,08% | 100,00% | ||
| MOYENNE | 22,88% | 66,10% | 1,69% | 5,08% | 0,00% | 4,24% | 100,00% | ||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| HOMMES | 7 | 26 | 0 | 1 | 0 | 0 | 34 | ||
| 20,59% | 76,47% | 0,00% | 2,94% | 0,00% | 0,00% | 100,00% | |||
| FEMMES | 2 | 17 | 1 | 2 | 0 | 3 | 25 | ||
| 8,00% | 68,00% | 4,00% | 8,00% | 0,00% | 12,00% | 100,00% | |||
| TOTAL | 9 | 43 | 1 | 3 | 0 | 3 | 59 | ||
| 15,25% | 72,88% | 1,69% | 5,08% | 0,00% | 5,08% | 100,00% | |||
|
|
|||||||||
|
|
|||||||||